Use of the ganciclovir implant for treating cytomegalovirus retinitis secondary to immunosuppression after bone marrow transplantation

American Journal of Ophthalmology

Volumn 123, Issue 5, 1997, Pages 702-703

  McAuliffe, P F ^a   Hall, M J ^a   Castro Malaspina, H ^a   Heinemann, M H ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CONCANAVALIN A; FOSCARNET; GANCICLOVIR; MITOGENIC AGENT; PHYTOHEMAGGLUTININ;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CASE REPORT; CILIARY DISK; CYTOMEGALOVIRUS INFECTION; DRUG IMPLANT; FEMALE; HUMAN; IMMUNE DEFICIENCY; INTRAVENOUS DRUG ADMINISTRATION; INTRAVITREAL DRUG ADMINISTRATION; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDER; NEPHROTOXICITY; PRIORITY JOURNAL; RETINITIS; SUSTAINED RELEASE PREPARATION; VISUAL ACUITY;

EID: 0030974117     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(14)71090-6     Document Type: Article

References (5)

1. Hoover DR Saah AJ Bacellar H Clinical manifestations of AIDS in the era of Pneumocystis prophylaxis: multicenter AIDS cohort study N Engl J Med 329 1993 1922 1926
2. Rahhal FM Rosberger DF Polsky B Thoron L Heinemann M.-H Cytomegalovirus retinitis in a patient with a normal helper T-cell (CD4) count Arch Ophthalmol 111 1993 1325 1326
3. Martin DF Parks DJ Mellow SD Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant Arch Ophthalmol 112 1994 1531 1539
4. Morley MG Duker JS Ashton P Robinson MR Replacing ganciclovir implants Ophthalmology 102 1995 388 392
5. Charles NC Steiner GC Ganciclovir intraocular implant: a clinicopathologic study Ophthalmology 103 1996 416 421